A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
A multicenter, open label, escalating dose study to assess the tolerability and the safety
and to explore the efficacy and the pharmacokinetics of ND0801 in adult patients with
attention deficit/hyperactivity disorder (ADHD).